| ID | Name | CAS | Properties |
MW (g/mol) |
| 119-834-4 |
L-Pipecolic acid, N(O,S)-ethoxycarbonyl, (S)-(+)-3-methyl-2-butyl ester
|
|
3 | 271.36 |
| 119-836-2 |
Isonipecotic acid, N-(2,6-difluoro-3-methylbenzoyl)-, undecyl ester
|
|
3 | 437.57 |
| 119-903-7 |
Pyridine, 1-acetyl-5-(1-acetyl-2-piperidinyl)-1,2,3,4-tetrahydro-
|
|
3 | 250.34 |
| 120-147-5 |
5,6-Dihydro-1,4,2-dioxazin-3-yl)-(2-hydroxyphenyl)methanone oxime, isomer 2
|
|
3 | 224.21 |
| 120-304-0 |
1-Piperazine ethanol, 4-[3-(2-trifluoromethyl-10-phenoxazinyl)propyl]-, dihydrochloride
|
|
3 | 494.38 |
| 120-307-7 |
5,5-Dimethyl-2-phenyl-4-propionyl-1,3,4-oxadiazoline
|
|
3 | 232.28 |
| 120-373-4 |
L-Proline, N-(2,6-difluoro-3-methylbenzoyl)-, hexyl ester
|
|
3 | 353.40 |
| 120-679-5 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-butyl-phosphorothioamidate
|
|
3 | 281.69 |
| 120-708-2 |
2,3-Dihydro-5-methyl-4-[(2-methyl-3-furyl)dithio]furan
|
|
3 | 228.34 |
| 120-802-7 |
2,2,2-Trifluoro-N-(4-methoxy-1,3-benzothiazol-2-yl)acetamide
|
|
3 | 276.24 |
| 120-805-4 |
N-Isopropyl-N'-methyl-N,N'-bis(trifluoroacetyl)-6-methylsulfanyl-1,3,5-triazine-2,4-diamine
|
|
3 | 405.32 |
| 120-865-8 |
1,3-bis[(1-Ethenylhexyl)oxy]-1,1,3,3-tetramethyldisiloxane
|
|
3 | 386.72 |
| 120-900-8 |
L-Proline, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, pentadecyl ester
|
|
3 | 513.63 |
| 121-038-5 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-(2-ethylbutyl)-phosphorothioamidate
|
|
3 | 309.74 |
| 121-097-0 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, pentyl ester
|
|
3 | 439.39 |
| 121-247-3 |
Silane, methylvinyl(2,4,4-trimethylpentyloxy)(methylvinyl(2,4,4-trimethylpentyloxy)silyloxy)-
|
|
3 | 414.78 |
| 121-475-0 |
R,S-3',4'-methylenedioxy-«alpha»-pyrrolidinopropiophenone-M (desmethylene-oxo-), diethylated
|
|
3 | 305.37 |
| 121-496-7 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-(1-ethylpropyl)-phosphorothioamidate
|
|
3 | 295.71 |
| 121-625-3 |
3-Amino-3-(2-chlorophenyl)propionic acid, N-dimethylaminomethylene-, methyl ester
|
|
3 | 268.74 |
| 121-626-2 |
3-Amino-3-(4-fluorophenyl)propionic acid, N-dimethylaminomethylene-, methyl ester
|
|
3 | 252.29 |
| 121-701-8 |
Phosphonic acid, methyl-, o,o-bis-(3,3-dimethyl butyl) ester
|
|
3 | 264.35 |
| 121-783-8 |
1,3-Disiloxane, 1,3-dimethyl, 1,3-bis-(chloromethyl), 1,3-bis-(1-chloroethyl)
|
|
3 | 328.21 |
| 121-934-0 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N,N-dimethyl-phosphorothioamidate
|
|
3 | 253.63 |
| 121-994-4 |
2,5-Cyclohexadien-1-one, 2,6-dichloro-4-(chloroimino)-
|
101-38-2 |
3 | 210.44 |
| 122-066-3 |
3-Amino-2,3-dihydrobenzoic acid, N-dimethylaminomethylene-, butyl ester
|
|
3 | 250.34 |
| 122-067-2 |
3-Amino-2,3-dihydrobenzoic acid, N-dimethylaminomethylene-, ethyl ester
|
|
3 | 222.29 |
| 122-110-3 |
1H-1,5-Benzodiazepine-2,4(3H,5H)-dione, 8-chloro-1-phenyl-
|
22316-55-8 |
3 | 286.71 |
| 122-152-7 |
Methyl 5-«beta»-cholan-12-«alpha»-ol-3-one-24-oate, oxime, TMS # 1
|
|
3 | 563.96 |
| 122-270-6 |
Pyrazolo[1,5-d][1,2,4]triazin-3-one, 2,5,6-trimethyl-7-phenyl
|
|
3 | 256.30 |
| 122-341-7 |
L-Proline, N-(2,6-difluoro-3-methylbenzoyl)-, undecyl ester
|
|
3 | 423.54 |
| 122-342-6 |
L-Proline, N-(2,6-difluoro-3-methylbenzoyl)-, tetradecyl ester
|
|
3 | 465.62 |
| 122-343-5 |
L-Proline, N-(2,6-difluoro-3-methylbenzoyl)-, dodecyl ester
|
|
3 | 437.56 |
| 122-344-4 |
L-Proline, N-(2,6-difluoro-3-methylbenzoyl)-, heptyl ester
|
|
3 | 367.43 |
| 122-346-2 |
L-Proline, N-(2,6-difluoro-3-methylbenzoyl)-, nonyl ester
|
|
3 | 395.49 |
| 122-350-7 |
L-Proline, N-(2,6-difluoro-3-methylbenzoyl)-, pentadecyl ester
|
|
3 | 479.64 |
| 122-399-4 |
L-Proline, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, dodecyl ester
|
|
3 | 471.56 |
| 122-534-3 |
(1'S,3R,4a'S,5a'S,10a'S)-Methyl 1'-methyl-2-oxo-1',4a',5',5a',7',8',10',10a'-octahydrospiro[indoline-3,6'-pyrano[3,4-f]indolizine]-4'-carboxylate
|
5629-60-7 |
3 | 368.43 |
| 122-539-8 |
11H-Pyrido[2,1-b]quinazolin-11-one, 1,2,3,4,6,7,8,9-octahydro, 6-methyl
|
|
3 | 218.30 |
| 122-570-3 |
9-Methyl-6,7,8,9-tetrahydro-pyrido[ 2,1-b]quinazolin-11-one
|
|
3 | 214.26 |
| 122-615-3 |
1-(2-Methylbutoxy)-7-heptyl-2,2,4,4,6,6-hexamethyl-1,3,5,7-tetraoxa-2,4,6-trisilaheptane
|
|
3 | 408.80 |
| 122-640-5 |
5-methyl-2,3-bis(1'-pyrrolidinyl)-2-cyclopenten-1-one
|
|
3 | 234.34 |
| 122-767-5 |
3-[(Pyrrol1,1,3,3-tetramethyl-3-[(1-methylheptyl)oxy]disiloxanylmorphooxy)methyl]pyridine
|
|
3 | 369.65 |
| 122-840-3 |
Octahydrodipyrido[1,2-a:1',2'-d]pyrazine-6,12(2H,6aH)-dione
|
|
3 | 222.28 |
| 122-847-6 |
L-Proline, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, hexadecyl ester
|
|
3 | 527.66 |
| 122-923-1 |
trans-2-Hydroxycinnamic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
3 | 392.68 |
| 122-953-8 |
7-(Acetoxymethyl)-2,3,5,7a-tetrahydro-1H-pyrrolizin-1-yl tiglate
|
|
3 | 279.33 |
| 122-958-3 |
Androst-4-ene-3.alpha.,17.beta.-diol , per-TMS
|
|
3 | 434.81 |
| 122-964-6 |
Pyrrolidino[1,2-e]-4H-1,3,5-dithiolane, 2-butyl-4-methyl
|
|
3 | 231.42 |
| 123-105-8 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-(1-methylpropyl)-phosphorothioamidate
|
|
3 | 281.69 |
| 123-174-2 |
O-Ethyl-O-(1,1-difluoro-2-chloroethyl)-N-(1,1-dimethylethyl)-phosphorothioamidate
|
|
3 | 295.72 |
| 123-201-1 |
L-Proline, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, tetradecyl ester
|
|
3 | 499.61 |
| 123-559-5 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, hexadecyl ester
|
|
3 | 593.68 |
| 123-592-8 |
Cyclopentane-1,2-dione, 3,3,5,5-tetramethyl, bis(o-methyloxime)-(Z,Z)-
|
140401-51-0 |
3 | 212.29 |
| 123-631-4 |
Formosanan-16-carboxylic acid, 19-methyl-2-oxo-, methyl ester, (19«alpha»)-
|
509-80-8 |
3 | 368.43 |
| 123-653-0 |
2,4-Pregnadien-(2,3-d)isoxazol-17.alpha.-ethynyl-17.beta.-ol, TMS
|
|
3 | 409.65 |
| 123-686-4 |
3,5-Dihydroxybenzoic acid, bis(tert-butyldimethylsilyl) ether, tert-butyldimethylsilyl ester
|
|
3 | 496.90 |
| 123-817-8 |
5,5-Diethyl-2-methyl-4-propionyl-1,3,4-oxadiazoline
|
|
3 | 198.27 |
| 123-964-5 |
6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-one, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,8aS)-
|
510-77-0 |
3 | 285.34 |
| 123-994-2 |
1,3,2-Diazaphosphol-4-ene, 2-ethyl-1,3-dibutyl-4,5-dimethyl-
|
106054-01-7 |
3 | 256.37 |
| 124-022-9 |
5-«alpha»-Pregnan-3-«beta»,21-diol-20-one, MeTMS
|
|
3 | 478.86 |
| 124-026-5 |
2-Butenoic acid, 2-methyl-,8-methyl-6-(1-oxopropoxy)-8-azabicyclo[3.2.1]oct-3-yl ester, [1R-[1«alpha»,3«beta»(E),5«alpha»,6«alpha»]]-
|
54354-59-5 |
3 | 295.37 |
| 124-148-0 |
Pyrazolo[1,5-d][1,2,4]triazin-3-one, 2,6-dimethyl-7-phenyl
|
|
3 | 242.28 |
| 124-159-8 |
3,4-Dihydroxybenzoic acid, bis(tert-butyldimethylsilyl) ether, tert-butyldimethylsilyl ester
|
|
3 | 496.90 |
| 124-238-0 |
N-(6-Methoxy-1,3-benzothiazol-2-yl)-2,2,3,3,3-pentafluoropropanamide
|
|
3 | 326.24 |
| 124-267-8 |
O-Ethyl-O-(1,1-difluoro-2-chloroethyl)-N-methyl-phosphorothioamidate
|
|
3 | 253.64 |
| 124-269-6 |
D-Pipecolic acid, N(O,S)-ethoxycarbonyl, (S)-(+)-3-methyl-2-butyl ester
|
|
3 | 271.36 |
| 124-293-9 |
Nicotinic acid, 1,2-dihydro-4,6-dimethyl-5-nitro-2-oxo-, ethyl ester
|
6972-37-8 |
3 | 240.21 |
| 124-317-2 |
Cyclopentane-1,2-dione, 3,3,5,5-tetramethyl, bis(o-methyloxime)-(E,Z)-
|
140210-45-3 |
3 | 212.29 |
| 124-350-5 |
2-Chloro-10-(3'-dimethylaminopropyl)phenothiazine, 5-oxide, hydrochloride, monohydrate
|
|
3 | 389.34 |
| 124-391-0 |
2,6-Piperidinedione, 1-[(octahydro-2H-quinolizin-1-yl)methyl]-, (1R-cis)-
|
18688-40-9 |
3 | 264.36 |
| 124-453-1 |
1,3,2-Diazaphosphol-4-ene, 2-ethoxy-1,3-dibutyl-4,5-dimethyl-
|
|
3 | 272.37 |
| 124-523-3 |
L-Proline, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, hexyl ester
|
|
3 | 387.39 |
| 124-527-9 |
L-Proline, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, decyl ester
|
|
3 | 443.50 |
| 124-533-2 |
L-Proline, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, butyl ester
|
|
3 | 359.34 |
| 124-571-0 |
5-Methyl-9-azabicyclo[3.3.1]nonan-3-one, N-trifluoroacetyl
|
|
3 | 249.23 |
| 124-612-4 |
Pentan-2-one, 4-methyl-4-ethoxyamino, O-ethyloxime, syn
|
|
3 | 202.30 |
| 124-628-7 |
2-Nonenoic acid, 4-hydroxy, TMS, methyl ester, # 2
|
|
3 | 258.43 |
| 124-634-0 |
Pyrrolidin-2-one, 1-[1-(4-carbomethoxyphenyl)butan-1-ol-2-yl]-
|
|
3 | 291.34 |
| 124-641-2 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-isobutyl-phosphorothioamidate
|
|
3 | 281.69 |
| 124-647-6 |
Pregn-5-en-20-one, 3,16-bis[(trimethylsilyl)oxy]-, O-methyloxime, (3«beta»,16«alpha»)-
|
57305-31-4 |
3 | 505.88 |
| 124-670-0 |
2-Hydroxy-5-methoxybenzoic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
3 | 396.68 |
| 124-671-9 |
R,S-4'-Methoxy-«alpha»-pyrrolidinopropiophenone-M (desmethyl-3HO-), 2ET
|
|
3 | 291.39 |
| 124-692-6 |
O-Ethyl-O-(1,1-difluoro-2-chloroethyl)-N,N-dimethyl-phosphorothioamidate
|
|
3 | 267.66 |
| 124-747-5 |
Benzenepropanoic acid, 3-methoxy-«alpha»,4-bis[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
55887-61-1 |
3 | 428.74 |
| 124-791-6 |
20.alpha.-hydroxy-pregn-4-en-3-one, MO-TMS, anti
|
|
3 | 417.71 |
| 124-793-4 |
6H-Pyrido[2,1-b]quinazolin-6-one, 7,8,9,10-tetrahydro-8-methyl
|
|
3 | 214.26 |
| 124-859-1 |
(E)-Methyl 2-((1'R,6'R,7'S,8a'S)-6'-ethyl-2-oxo-3',5',6',7',8',8a'-hexahydro-2'H-spiro[indoline-3,1'-indolizin]-7'-yl)-3-methoxyacrylate
|
76-66-4 |
3 | 384.47 |
| 124-895-1 |
11H-Pyrido[2,1-b]quinazolin-11-one, 1,2,3,4,6,7,8,9-octahydro, 9-methyl
|
|
3 | 218.30 |
| 124-907-7 |
11«alpha»,15«alpha»-dihydroxy-9-ketoprosta-5,13-dienoic acid, EO TMS # 2
|
|
3 | 612.09 |
| 124-968-0 |
Galanthan-1-ol, 3,12-didehydro-9,10-[methylenebis(oxy)]-, (1«alpha»)-
|
477-12-3 |
3 | 271.31 |
| 125-109-2 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, dodecyl ester
|
|
3 | 485.58 |
| 125-279-4 |
N,N-Dimethyl-N'-(3-methyl-2,6-dioxotetrahydro-2H-pyran-3-yl)imidoformamide
|
|
3 | 198.22 |
| 10-068-5 |
3«alpha»,6«alpha»,7«beta»,12«alpha»-Tetrahydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl ether
|
|
2 | 727.32 |
| 10-210-6 |
2,2,4,6,8,10-hexamethyl-4,6,8,10-tetra(2-cyanoethyl)-[1,3,5,7,9,2,4,6,8,10]cyclopentasiloxane
|
|
2 | 526.91 |
| 10-421-2 |
5«beta»-Pregnane-3«alpha»,17«alpha»,20«alpha»-triol, (3,20-O)-diTBDMSi
|
|
2 | 565.03 |
| 10-423-0 |
5-«alpha»-Androst-1-ene-3-«beta»,17-«beta»-diol, TMS
|
|
2 | 434.80 |
| 10-453-7 |
5-[(1E)-3,3-dimethyl-1-triazenyl]-1h-imidazole-4-carbohydrazide
|
116401-55-9 |
2 | 197.20 |
| 10-635-5 |
2,2,4,4,6,8,8,10,12-nonamethyl-8,10,12-tri(2-cyanoethyl)-[1,3,5,7,9,11,2,4,6,8,10,12]cyclohexasiloxane
|
|
2 | 562.04 |
| 10-945-1 |
Formamide, n-benzyl-n-[3-benzyl-6-benzylamino-4-thioxo-5-pyrimidinyl]-
|
|
2 | 440.57 |
| 10-950-5 |
DL-3-Aminoisobutyric acid, N-(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
|
2 | 331.65 |
|
« Previous Results
Next Results »
|